News | 29 July 2012
The grades of five Biotechnology stocks are better this week, according to the Portfolio Grader database. Every one of these stocks has an ?A? (?strong buy?) or ?B? overall (?buy?) rating. Array BioPharma (NASDAQ:ARRY) is progressing from last week's ...
Click on the link to read the full article at Investorplace.com
(This link will open in a new window)